Otilimab (development codes MOR103 and GSK3196165) is a fully human antibody which has been developed by the biotechnology company MorphoSys. It can also...
8 KB (722 words) - 15:17, 22 March 2023
(2003). In 2008, the company’s first proprietary antibody MOR103 (now otilimab) entered clinical development. Following the publication of promising results...
17 KB (1,409 words) - 10:53, 21 June 2024
biological target may reduce the inflammation or damage. Some drugs (e.g. otilimab) are being developed to block GM-CSF. In critically ill patients GM-CSF...
17 KB (1,672 words) - 11:59, 30 August 2023
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
31 KB (3,428 words) - 11:40, 29 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
9 KB (457 words) - 08:58, 6 August 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
35 KB (3,892 words) - 12:38, 3 August 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
26 KB (2,188 words) - 05:17, 13 June 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
62 KB (6,833 words) - 02:25, 22 June 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
34 KB (3,186 words) - 02:10, 16 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
26 KB (2,102 words) - 02:19, 16 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
36 KB (2,981 words) - 17:57, 23 June 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
62 KB (7,065 words) - 05:17, 28 June 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
24 KB (1,700 words) - 04:21, 2 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
16 KB (1,412 words) - 06:19, 26 June 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
27 KB (3,227 words) - 11:45, 29 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
4 KB (443 words) - 07:08, 27 April 2024
oxLDL Otelixizumab mab chimeric/ humanized CD3 diabetes mellitus type 1 Otilimab mab human GMCSF osteoarthritis, rheumatoid arthritis Otlertuzumab mab humanized...
135 KB (4,054 words) - 22:35, 2 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
33 KB (3,686 words) - 07:30, 20 May 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
46 KB (4,534 words) - 06:57, 1 April 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
16 KB (1,124 words) - 12:50, 14 January 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
31 KB (2,727 words) - 21:26, 26 January 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
24 KB (2,932 words) - 03:26, 14 June 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
33 KB (2,917 words) - 16:32, 16 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
13 KB (1,176 words) - 21:00, 10 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
25 KB (2,344 words) - 09:58, 6 August 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
11 KB (666 words) - 04:47, 6 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
36 KB (4,573 words) - 00:48, 7 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
30 KB (2,727 words) - 19:16, 6 April 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
43 KB (3,613 words) - 02:13, 16 July 2024
Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab M-CSF (CSF1) Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating...
9 KB (1,066 words) - 13:45, 13 August 2023